Subscribe
Stay up to date with us

Pet Industry News

The deals, launches, and strategic moves behind the brands and operators shaping the industry.

Submit a Press Release
Read article
Featured
3 min read

Pets will shape travel plans for 68% of owners, Subaru survey finds

A Subaru-commissioned Talker Research survey of 2,000 pet-owning drivers, released October 13th, 2026, says 68% expect their pet to affect travel plans this year and 73% would drive instead of fly to bring the pet. New in this release, 10% may host, 10% may shorten a trip and 8% may skip gatherings. In our view, the trip-length and planning numbers are the ones sitters and kennels can use.

Read article
Pets will shape travel plans for 68% of owners, Subaru survey finds
Read article
Northwest Naturals Recall Marks Raw Food's Third FDA Pathogen Hit Since June
Regulatory
4 min read

Northwest Naturals Recall Marks Raw Food's Third FDA Pathogen Hit Since June

FDA testing found Salmonella and Listeria monocytogenes in two Northwest Naturals raw pet food products, prompting a nationwide recall on August 28th. It's the company's second recall in two years and the third FDA-caught pathogen recall in the raw and minimally processed category since June, arriving three weeks after the DOJ sued Darwin's Natural Pet Products over a similar contamination rate.

Read article
Read article
Elanco's $150M Kansas Expansion Chases Runaway Befrena Demand
Strategy
5 min read

Elanco's $150M Kansas Expansion Chases Runaway Befrena Demand

Elanco finished a $150 million expansion of its Elwood, Kansas biologics plant, more than quadrupling capacity for Befrena and Trutect after Befrena demand ran two times above expectations since its May launch. CEO Jeff Simmons said the company expects unconstrained supply by early 2027, a capital bet that its head-to-head challenge to Zoetis's Cytopoint dermatology franchise is paying off.

Read article
Read article
Cronus Pharma Ends Elanco's Onsior Injection Monopoly With First Generic
Launches
5 min read

Cronus Pharma Ends Elanco's Onsior Injection Monopoly With First Generic

Cronus Pharma began shipping the first FDA-approved generic robenacoxib injection this week, ending Elanco's decade of exclusivity on its branded Onsior painkiller. The launch closes the loop on generic competition across both the tablet and injectable forms of the drug within an eight-month span.

Read article
Read article
Revival Animal Health Faces a Third Recall in Four Months
Regulatory
4 min read

Revival Animal Health Faces a Third Recall in Four Months

Revival Animal Health has recalled its Shelter's Choice and Breeder's Edge feline milk replacers nationwide over inconsistent vitamin and mineral levels, the company's third such recall in four months. Nine complaints of gastrointestinal and bone-development issues have been logged, with no confirmed illnesses.

Read article
Read article
Pumpkin Unbundles Wellness Perks From Its Own Insurance Policy
Strategy
5 min read

Pumpkin Unbundles Wellness Perks From Its Own Insurance Policy

Pumpkin has replaced its insurance-bundled Preventive Essentials add-on with a standalone Pumpkin Wellness Club membership open to any pet owner, insured or not. The shift turns wellness into its own recurring-revenue line and tests whether rivals follow with their own unbundled plans.

Read article
Read article
Phibro Beats Fiscal 2026 Estimates, Then Confirms a Plant Closure
Earnings
4 min read

Phibro Beats Fiscal 2026 Estimates, Then Confirms a Plant Closure

Phibro Animal Health closed fiscal 2026 with a broad earnings beat, full-year sales up 17%, and raised guidance for 2027. The same day, it confirmed a Chicago Heights, Illinois plant closure tied to consolidating capacity after its 2024 feed-additive acquisition, a sign the deal has cleared its integration runway.

Read article